Oramed Pharmaceuticals Inc Net Asset Quality Index
Oramed Pharmaceuticals Inc net asset quality index. Oramed Pharmaceuticals Inc (ORMP) has a Net Asset Quality Index of 88.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $268.85 Million minus total liabilities of $30.57 Million yields net assets of $238.28 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Oramed Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Oramed Pharmaceuticals Inc (2005–2025)
Net asset quality index of Oramed Pharmaceuticals Inc from 2005 to 2025. This chart shows how Oramed Pharmaceuticals Inc's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the index stands at 88.6%, representing net assets of $238.28 Million against total assets of $268.85 Million USD. Check Oramed Pharmaceuticals Inc (ORMP) strategic investment index to assess the company's strategic physical and investment asset allocation.
Oramed Pharmaceuticals Inc Net Asset Quality Index by Year (2005–2025)
Oramed Pharmaceuticals Inc net asset quality index by year from 2005 to 2025. The table below presents the year-by-year Net Asset Quality Index for Oramed Pharmaceuticals Inc from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Oramed Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.5% | $199.74 Million | $230.86 Million | $31.12 Million | ▼ -7.1 pp |
| 2024 | 93.6% | $145.35 Million | $155.28 Million | $9.93 Million | ▲ +19.7 pp |
| 2023 | 73.9% | $162.89 Million | $220.55 Million | $57.66 Million | ▼ -19.7 pp |
| 2022 | 93.5% | $151.16 Million | $161.64 Million | $10.49 Million | ▲ +2.5 pp |
| 2021 | 91.0% | $116.52 Million | $128.00 Million | $11.48 Million | ▲ +17.4 pp |
| 2020 | 73.7% | $32.88 Million | $44.63 Million | $11.75 Million | ▲ +17.7 pp |
| 2019 | 55.9% | $19.39 Million | $34.66 Million | $15.27 Million | ▼ -9.7 pp |
| 2018 | 65.6% | $31.11 Million | $47.40 Million | $16.29 Million | ▲ +15.9 pp |
| 2017 | 49.7% | $19.24 Million | $38.71 Million | $19.47 Million | ▼ -11.5 pp |
| 2016 | 61.1% | $26.19 Million | $42.83 Million | $16.64 Million | ▼ -33.1 pp |
| 2015 | 94.2% | $24.83 Million | $26.35 Million | $1.53 Million | ▼ -1.2 pp |
| 2014 | 95.4% | $20.79 Million | $21.80 Million | $1.01 Million | ▲ +1.5 pp |
| 2013 | 93.9% | $8.13 Million | $8.66 Million | $529.41K | ▲ +22.5 pp |
| 2012 | 71.4% | $3.78 Million | $5.29 Million | $1.52 Million | ▼ -14.7 pp |
| 2011 | 86.1% | $3.72 Million | $4.33 Million | $602.02K | ▲ +28.9 pp |
| 2010 | 57.2% | $830.27K | $1.45 Million | $620.62K | ▼ -27.0 pp |
| 2009 | 84.2% | $2.75 Million | $3.26 Million | $515.66K | ▲ +0.8 pp |
| 2008 | 83.4% | $4.59 Million | $5.51 Million | $913.95K | ▲ +56.9 pp |
| 2007 | 26.5% | $513.00K | $1.94 Million | $1.42 Million | ▲ +272.1 pp |
| 2006 | -245.6% | $-432.72K | $176.19K | $608.91K | ▲ +3310.6 pp |
| 2005 | -3556.2% | $-44.81K | $1.26K | $46.07K | — |